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OBJECTIVE: Osteoporosis increases the risk of bone fractures and may impair fracture healing. The aim of this study
was to investigate whether alpha-tocopherol can improve the late-phase fracture healing of osteoporotic bones in
ovariectomized rats.
METHOD: In total, 24 female Sprague-Dawley rats were divided into three groups. The first groupwas sham-operated,
and the other two groups were ovariectomized. After two months, the right femora of the rats were fractured under
anesthesia and internally repaired with K-wires. The sham-operated and ovariectomized control rat groups were
administered olive oil (a vehicle), whereas 60 mg/kg of alpha-tocopherol was administered via oral gavage to the
alpha-tocopherol group for six days per week over the course of 8 weeks. The rats were sacrificed, and the femora
were dissected out. Computed tomography scans and X-rays were performed to assess fracture healing and callus
staging, followed by the assessment of callus strengths through the biomechanical testing of the bones.
RESULTS: Significantly higher callus volume and callus staging were observed in the ovariectomized control group
compared with the sham-operated and alpha-tocopherol groups. The ovariectomized control group also had
significantly lower fracture healing scores than the sham-operated group. There were no differences between the
alpha-tocopherol and sham-operated groups with respect to the above parameters. The healed femora of the
ovariectomized control group demonstrated significantly lower load and strain parameters than the healed femora
of the sham-operated group. Alpha-tocopherol supplementation was not able to restore these biomechanical
properties.
CONCLUSION: Alpha-tocopherol supplementation appeared to promote bone fracture healing in osteoporotic rats
but failed to restore the strength of the fractured bone.
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INTRODUCTION
Osteoporosis is a condition of skeletal fragility that is
characterized by decreased bone mass and the microarchitec-
tural deterioration of bone tissue, which lead to an increased
risk of bone fractures (1). Several anti-osteoporotic agents, such
as estrogen replacement and bisphosphonate, are currently
available. However, poor compliance with osteoporosis
medication regimens is a serious problem; this issue may be
associated with patients of lower educational status (2).
Postmenopausal osteoporosis is the most common form of
age-related bone loss (3). Fractures secondary to osteoporosis
are more common in women than in men, occurring with a
one in three incidence ratio in women and a one in five
incidence ratio in men (4). These types of fractures are also
more common in Caucasians and Asians than African
Americans and Latinos (5).
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Fracture healing is a natural process that occurs in both
normal and osteoporotic fractured bones. It is a complex
process with three distinct phases: the reactive phase, the
reparative phase and the remodeling phase (6). The reactive
phase, which occurs immediately after fracture, lasts for
approximately one week and is characterized by inflamma-
tion of the injured region and the formation of granulation
tissue. The reactive phase is followed by the reparative
phase, which involves the formation of the fracture callus
and the deposit of lamellar bone. The final phase is the
remodeling phase, which occurs approximately two months
after fracture and involves the reshaping of the fractured
bone to an approximation of its original contours.
The fracture healing process is further complicated in
osteoporotic fractures. Previously published studies have
demonstrated that osteoporosis can delay callus maturation
and thereby decelerate fracture healing (7). Osteoporotic
bone may completely heal after fracture, even under
conditions of low bone density, low estrogen and/or low
calcium, but the healing process may require a more
extended period of time (8).
During the healing process, free radicals are generated
that may impair healing, especially in the post-menopausal
state, which has been associated with increased oxidative
stress. Antioxidants, such as vitamin E, may therefore
facilitate fracture healing by scavenging these free radicals
and relieving oxidative stress (9-11). Piper sarmentosum,
which contains antioxidants, has been found to improve
fracture healing in osteoporotic states, as evidenced by a
reduction in callus volumes and callus scores (12). Vitamin
E, a fat-soluble vitamin with chain-breaking ability, has
been demonstrated to increase bone trabecular formation
(13,15) and prevent bone calcium loss in ovariectomized rats
(14). There have been few studies regarding the effects of a-
tocopherol, the most abundant form of vitamin E, on the
fracture healing of normal bones. Sarisozen et al. (15)
showed that a-tocopherol supplementation did not accel-
erate the fracture healing process in normal rats. However,
Durak et al. (16) found that a-tocopherol supplementation
was able to promote bone fracture healing in normal rabbits.
Both of these studies addressed the effect of a-tocopherol on
the fracture healing of normal bones; however, neither
study examined the fracture healing of osteoporotic bones.
Previously, we performed a study on the effects of a-
tocopherol on the early phase of osteoporotic fracture
healing, and we found that a-tocopherol supplementation
facilitated the activities of antioxidants within the fractured
osteoporotic bones, allowing these antioxidants to overcome
the excessive free radicals released during the early phase of
fracture healing (17). Therefore, the aim of the current study
was to use an ovariectomized rat model to determine the
effects of a-tocopherol supplementation on the late-phase
fracture healing of osteoporotic bones.
MATERIALS AND METHODS
Animals and treatment
This study used 24 female Sprague-Dawley rats, each of
which weighed between 250 and 300 g. These rats were
divided into three groups; the first group was sham
operated (SO), and the other two groups were ovariecto-
mized. After two months, which allowed for osteoporosis to
develop in the ovariectomized rats, the right femora of all of
the rats were fractured under anesthesia using a blunt
guillotine method in accordance with Vialle et al. (18). All of
the procedures were performed aseptically. Briefly, the rats
were anesthetized using ketamine and xylazil (in a 1:1 ratio),
which were administered intramuscularly at a dose of
0.1 ml/100 g weight. Iodine was then applied, and a small
incision was made at the right knee of each rat. The right
patella of each rat was dislocated, and a Kirschner wire (K-
wire) (1.0 mm in diameter) was inserted with a drill into the
intramedullary canal of the right femur for internal fixation.
The right patella was relocated, and the incision was closed
with sutures (nylon 4.0). A fracturer device was then used to
fracture the right femur. This device used the guillotine
principle to fracture the femur, thereby ensuring that a
closed and standardized fracture was consistently pro-
duced. In particular, for each fracture, a three-point system
was employed in which a 500 g blunt steel bar was dropped
on the mid-diaphysis of a femur that was supported by two
metal bases. The fracturer device has three platforms, each
measuring 12.5 cm by 45 cm. The height from the middle
platform to the lowest platform is 30 cm, and this height
difference represents the distance through which the 500 g
bar falls to produce the fractures. The upper platform, which
is located 10 cm above the middle platform, helps to stabilize
the construct and the steel bar, and the trigger that releases
the steel bar is found on this platform. Baytril was injected
intramuscularly to achieve perioperative antibiotic prophy-
laxis. For analgesic purposes, the rats were subcutaneously
injected every 12 hours with buprenorphine at a dose of
0.3 mg/1 kg rat weight. The right femora of the rats were
immediately X-rayed using an X-ray machine (Proteus XR/a,
GE Healthcare, North Grandview, Waukesha, USA) to
ensure that fractures had occurred at mid-diaphysis and that
the K-wires were correctly inserted (Figure 1A). The ratswere
allowed unrestricted weight-bearing activities after they
recovered from the anesthesia.
The ovariectomized rats were then randomly divided into
an ovariectomized control (OVXC) group and an a-toco-
pherol-treated (ATF) group. All of the rats were housed in
individual cages at room temperature under natural day/
night cycle conditions. They were fed rat chow (Gold Coin,
Malaysia) and provided with deionized water ad libitum. The
ATF-treated group was given a-tocopherol acetate (Sigma,
USA) at a dose of 60 mg/kg rat weight. The SO and OVXC
groups were given olive oil (Bertolli, Italy), which acted as a
vehicle. Olive oil was also used as a diluent for the a-
tocopherol. Both olive oil and a-tocopherol were adminis-
tered via oral gavage for six days per week over the course of
eight weeks (14). The rats were then euthanized, and the
fractured femur was carefully removed to prevent any
damage to the bone. Post-mortem examinations of the rats
were performed to confirm their postmenopausal conditions,
and the atrophy of the uterus in each rat was observed. The
femur samples were evaluated for fracture healing and callus
strength immediately after they were harvested. During the
short period between the harvesting and the testing of the
femora, they were kept at 4 C˚ andwrapped in gauze that had
been soaked with phosphate-buffered solution to minimize
degradation and drying. This study was approved by the
UKM Animal Ethics Committee (FP/FAR/2008/NAZRUN/
13-FEB/217-FEB-2008-FEB2010).
Computed tomography scanning
The femora were scanned using a computed tomography
(CT) system (Somatom Sensation 64, Germany), which uses
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an X-ray tube (120 kV; 40 mAs) to produce a narrow fan
beam of X-rays. The CT scans were performed at a slice
thickness of 0.6 mm, an in-plane voxel size of 0.234 mm,
and a matrix size of 5126512 pixels. The manufacturer’s
software package (ver. 2006A) was used for image proces-
sing and data evaluation. The scanner was first calibrated
using a water phantom with a radiodensity of 0 Hounsfield
units (HUs) and a density of 1.0 g/cm3. The axial callus
volume was then measured from the CT images that were
obtained at 1 cm above and 1 cm below the diaphyseal
fracture. The total callus volume was calculated in terms of
mm/cm3 (Figure 1: BI, BII and BIII).
X-ray imaging
The femora were then examined through X-ray imaging.
Anteroposterior and lateral images were obtained using a
high-resolution digital radiography system (Philips Digital
Diagnost/Optimus 80 system) at 46 kV, 2.5 mAs and
10.6 ms of exposure. The stage of fracture healing was
assessed by a radiologist and quantified using a 5-point
radiographic scoring system that was modified from
Warden et al. (19) (Table 1A). The callus stage was also
assessed by the same radiologist using a 5-point scoring
system (Table 1B) based on visual assessments of the
appearance of the callus on the healed bones in the X-ray
images (20) (Figure 2: A, B and C).
Bone biomechanical testing
The harvested right femora were wrapped in gauze
dipped in phosphate-buffered saline (PBS) to prevent them
from drying out. The temperature was maintained at 4 C˚ to
slow bone degradation. The biomechanical strength of the
calluses was assessed using an Instron machine (Instron
Microtester 5848, Instron Corp, USA) with a Bluehill
software package. Each femur was placed in a three-point
bending configuration, and a load was applied at the speed
of 5 mm/min on the mid-point of the femora diaphysis on
the anterior surface, compressing the anterior surface and
increasing the tension of the posterior surface until the bone
re-fractured. The width between the two lower supports
Figure 1 - (A) An representative X-ray image used to confirm successful K-wire insertion and that the fractures were in the mid-
diaphyseal region. (B) Axial view of healed fractured femora from CT scan images. (I) SO group; (II) OVXC group; (III) ATF group.
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that held the femora was 10 mm. The load, stress, and strain
parameters were recorded by the software. For each femur,
a stress versus strain graph was plotted, and a Young’s
modulus value was derived from the gradient of the
resulting curve. This procedure was performed in a blinded
manner with respect to the test groups.
Statistical analyses
The results were expressed as the means ¡ the standard
error of each mean (SEM). The data analysis was performed
using the Statistical Package for Social Sciences software
(SPSS version 16.0, USA). The data were tested for normality
using the Kolmogorov-Smirnov test. The statistical tests
performed were ANOVA followed by Tukey’s HSD for
normally distributed data; for data that were not normally
distributed, the Kruskal-Wallis and Mann-Whitney tests
were performed. The level of significance was p,0.05.
RESULTS
CT scanning
After two months of treatment, CT scanning indicated
that the fractured femora of the rats in the OVXC group had
significantly higher callus volumes compared with the
fractured femora of rats in the SO group (Figure 3A). The
abundance of callus tissue in the OVXC group compared
with the SO group indicated the impaired fracture healing
of osteoporotic bones because by the late stages of fracture
healing, most of the callus should have been resorbed and
replaced with lamellar bone through the bone remodeling
process. The callus volume of the a-tocopherol group was
similar to the callus volume of the SO group. Therefore, a-
tocopherol supplementation appeared to be able to improve
the fracture healing of osteoporotic bone.
X-ray imaging
X-ray images of the healed fractured femur were
examined, and the stages of the fracture healing and the
callus were determined. The staging was assessed using the
previously described 5-point scoring system (Table 1B). For
fracture healing staging, all of the groups had average
scores above 2, indicating that progress in fracture healing
had occurred (Figure 3B). As expected, the OVXC group
scored lower than the SO group with respect to fracture
healing. The scores for the ATF group were not significantly
different from either the SO or the OVXC group. The callus
staging results were consistent with the CT scan results, as
the SO and ATF groups had significantly lower callus stages
than the OVXC group (Figure 3C). All of these data are
presented in Table 2.
Bone biomechanical testing
The strengths of the healed mid-diaphyseal fractures
were determined by conducting a biomechanical test on the
calluses. There were no significant differences in the stress
values for any of the groups (Figure 4A). Therefore, the
Table 1 - The 5-point radiographic scoring system
(modified from Warden et al. 2009) used to assess (A) the
fracture healing stage and (B) the callus stage (Nazrun et
al. 2010).
Score Description
0 No evidence of healing
1 Callus formation evident but fracture gap not bridged
2 Callus formation evident with bridging of the fracture gap
but fracture line evident
3 Callus formation evident with bridging of the fracture gap
with only faint fracture line
4 Fracture union
Score Description
0 No callus
1 Callus + (very minimal callus)
2 Callus ++ (minimal callus)
3 Callus +++ (moderate callus)
4 Callus ++++ (exuberant callus)
Figure 2 - X-ray images of a healed fractured femur from each group. (A) SO group; (B) OVXC group; (C) ATF group.
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Figure 3 - (A) The bar chart indicates the axial callus volumes, which were measured and calculated using CT scanning. (B) The bar chart
indicates the fracture healing stages obtained from the radiological scoring of X-ray images. (C) The bar chart indicates the callus
staging scores obtained from the radiological scoring of X-ray images. SO: sham-operated group; OVXC: ovariectomized control group;
ATF: ovariectomized + ATF-supplemented group; Values with the same alphabetical symbol are significantly different at p,0.05.
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calluses of all of the groups were able to handle similar
quantities of stress before they fractured. With respect to the
strain value, the SO group was found to have a significantly
higher strain value than either the OVXC group or the ATF
group. Therewas no significant difference in the strain values
observed for the OVXC and ATF groups (Figure 4B). The
same pattern was observed for the load values, as the SO
group had significantly higher load values than both the
OVXC and ATF groups, whereas the OVXC and ATF groups
did not differ significantly with respect to this metric
(Figure 4C). This result indicates that the calluses of the
fractured femora of the SO group were able to handle the
highest amount of strain and load, whereas the calluses of the
OVX and ATF groups had similarly inferior capabilities.
There were no significant differences in the Young’s modulus
parameter for the three groups (Figure 4D). All of the data for
bone biomechanical testing are presented in Table 3.
DISCUSSION
The main objective of this study was to evaluate the effects
of vitamin E (specifically, a-tocopherol) supplementation on
Table 2 - The axial callus volume measured and calculated using CT scan, fracture healing stage based on radiological
scoring assessed from X-ray images, and callus staging scores based on radiological scoring assessed from X-ray images.
CT Scan & X-ray SO OVXC ATF
Mean SD Mean SD Mean SD
Axial callus volume by CT scan (mm/cm3) 0.34 ¡0.05 0.59* ¡0.06 0.28# ¡0.04
Fracture healing stage by CT scan 3.5 ¡0.22 2.17* ¡0.17 2.67 ¡0.21
Callus staging by X-ray 1.5 ¡0.22 2.83* ¡0.17 1.17# ¡0.17
Figure 4 - (A) The bar chart illustrates the stress parameters derived from bone biomechanical testing. (B) The bar chart indicates the
strain parameters derived from bone biomechanical testing. (C) The bar chart illustrates the load parameters derived from bone
biomechanical testing. (D) The bar chart indicates the Young’s modulus values derived from bone biomechanical testing. SO: sham-
operated group; OVXC: ovariectomized control group; ATF: ovariectomized + ATF-supplemented group; Values with the same
alphabetical symbol are significantly different p,0.05.
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the late-phase fracture healing of osteoporotic bone. In this
study, rat femora were fractured two months after rat
ovariectomies, and a subset of the rats was supplemented
with a-tocopherol for an additional two months before being
sacrificed. Ovariectomized rats are an established model
for the study of postmenopausal osteoporosis (21,22) and
osteoporotic fractures (23,24). Previous studies have demon-
strated that bone mineral densities are significantly lower in
ovariectomized rats than in control rats at eight and 12 weeks
after ovariectomy (11). A study by Estai et al. demonstrated
that the expression of serum TGFb-1 was reduced and the
callus strength was compromised in rats at six weeks after
ovariectomy (25). Of the fracture techniques available (26-29),
we chose the guillotine method described by Vialle et al. in
2004 (18) because this method produces a consistent fracture
of the femur with less trauma to the surrounding tissues.
Thus, this methodmimics the conditions ofmost osteoporotic
fractures, which occur as a result of trivial force. Surgical
fractures may cause vascular injuries that increase the
incidence of either the delayed union or the non-union of
fractures (30).
The duration of fracture healing was critical in this study.
We allowed the fractured femur to heal for two months; this
duration was expected to correspond to the late phase of the
fracture healing process. In normal fracture healing, two
months of healing would be sufficient to allow the callus
formed earlier in the reparative phase to be mostly replaced
by lamellar bone. A longer duration of healing might not
allow us to detect any differences in the healing rate
between the examined groups, given that complete fracture
healing occurred at three months post-fracture in both
ovariectomized and sham-operated rats (8).
Oxidative stress is believed to be the underlying
pathology that causes bone loss in osteoporotic bones.
This mechanism explains why vitamin E (an antioxidant)
can protect osteoporotic bones against further bone loss (31)
and improve the fracture healing process. In fact, a study by
Maniam et al. (32) found that vitamin E both suppressed
lipid peroxidation and increased glutathione peroxidase
activity in the bone.
A recent study investigated the effects of a-tocopherol on
the early phase of osteoporotic fracture healing (17). In that
study, at two weeks after fracture (corresponding to the
early phase of fracture healing), the healing of the
ovariectomized control group was found to be inferior to
the healing of the sham-operated group, whereas the
radiological scoring of fracture healing (as measured by
fracture stages) was similar for the a-tocopherol and sham-
operated groups. In the present study, which addresses late-
phase fracture healing, similar findings were obtained. In
particular, the OVXC group had lower fracture stage scores
than the SO group. Callus staging indicated that a-
tocopherol supplementation could recover the fracture
healing ability of osteoporotic bone. In another study of
the early phase of fracture healing, the calcium supplemen-
tation of rats improved the radiologically assessed fracture
healing of osteoporotic bone but failed to restore the
strength of the healed fractured bones (20). Several studies
have demonstrated the beneficial effects of a-tocopherol on
bone metabolism. Smith et al. (33) reported that a-
tocopherol supplementation alters bone metabolism in
mature animals and protects against bone loss in the hind
limb of unloaded rats. Other studies have demonstrated
similar osteoprotective properties of vitamin E in other
animal models of bone loss, such as ovariectomized rats (34)
and aged (24 months old) mice (35). A study by Turk et al.
(36) reported that a-tocopherol has a positive effect on both
the early and late phases of fracture healing. The radi-
ological evaluation demonstrated that a-tocopherol supple-
mentation improved the late-phase fracture healing (60
days) of normal rats. In our study, the a-tocopherol
supplementation of ovariectomized rats did not produce
any significant improvements in the fracture healing stage
compared with unsupplemented ovariectomized rats.
However, vitamin E treatment did significantly improve
the fracture healing of ovariectomized rats with respect to
callus volume and callus staging.
The rats supplemented with a-tocopherol did not show
any signs or symptoms of toxicity throughout the eight
weeks of the study. Previous toxicity studies of vitamin E by
Ima et al. (37) showed that doses of palm vitamin E that
were much greater than the effective dose used to treat or
prevent osteoporosis (in particular, doses above 200 mg/kg)
may cause bleeding tendencies and renal impairment but
did not appear to produce liver toxicities.
In the rat model, the size of the fracture callus can be
approximately 400% larger than the bone itself before this
callus is resorbed to a bone-equivalent size during the
remodeling phase of fracture healing. In humans, a fracture
treated with a cast, splint or surgery is typically only
approximately 25 to 100% larger than the bone. Our findings
regarding callus volumes indicated that the SO and ATF
groups had similar callus volumes, which were lower than
the callus volumes of the OVXC group. At the second month
of fracture healing, which corresponds to the remodeling
phase, the excess callus should be actively resorbed.
Therefore, the smaller calluses of the SO and ATF groups
indicated that fracture healing was more advanced in those
groups than in the OVXC group. This evidence has proven
that a-tocopherol supplementation is able to promote the
fracture healing of osteoporotic bones of rats in which
osteoporosis had been induced through ovariectomies. This
result was consistent with the callus staging parameter,
which indicated that the SO and ATF groups had lower
callus stages than the OVXC group.
Because the callus volumes and stages of the SO and ATF
groups were similar, we would expect both of these groups
to have similar but superior callus strength relative to the
OVXC group. As expected, the ovariectomized rats had
lower load and strain values compared with the sham
Table 3 - The stress, strain, load, and Young’s modulus
parameter derived from the bone biomechanical testing.
Biomechanical
test SO C ATF
Mean SD Mean SD Mean SD
Flexure stress
(MPa)
1.73 ¡0.51 1.24 ¡0.33 1.95 ¡0.28
Flexure strain
(mm/mm)
6.25 ¡0.59 3.20* ¡0.21 4.03* ¡0.49
Flexure load (N) 212.23 ¡37.56 85.90* ¡19.93 109.27* ¡7.02
Modulus (MPa) 3.64 ¡0.24 4.17 ¡0.19 3.92 ¡0.13
SO: sham-operated group.
OVXC: ovariectomized control group.
ATF: ovariectomized + ATF-supplemented group.
p-values ,0.05 were considered to be significant (*p,0.01 vs. SO group,
#p,0.002 vs. OVXC group).
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group. However, we found that the a-tocopherol supple-
mentation of ovariectomized rats failed to improve the
ability of their calluses to withstand loads and strains.
A study by Norazlina et al. demonstrated that a-
tocopherol supplementation was unable to prevent the loss
of bone calcium in ovariectomized rats (14). Because
calcium is one of the main minerals in calluses, this
previous study may provide an explanation for why the
callus strength was not restored after a-tocopherol supple-
mentation. In a study of the fracture healing of tibias from
rats with osteoporosis induced by sciatic neurectomy,
Nordsletten et al. (38) found that 25 days after fracture,
callus formation and bone mineral density were higher in
the sciatic neurectomized rats, but the callus strengths of the
sciatic neurectomized rats and the normal control rats did
not differ significantly. Several other studies have produced
contrasting results regarding the strength of osteoporotic
bones after fracture healing. Langeland (39) reported that
the strength of fractured tibial bones at two weeks after
fracture did not differ significantly between ovariectomized
and normal control rats. Blythe and Buchsbaum (40)
reported similar findings in the same model at five weeks
after fracture.
In this study, although two months of a-tocopherol
treatment was sufficient to produce accelerated healing in
ovariectomized rats, this treatment did not appear to
improve the strength of the healed bone. Therefore, the a-
tocopherol treatment period may need to be increased to
produce improved bone strength. Alternatively, the admin-
istration of a higher dose of a-tocopherol may improve the
bone strength of osteoporotic rats.
We can conclude from this study that based on the X-ray
and CT scan results, the a-tocopherol supplementation of
osteoporotic rats appears to promote bone fracture healing;
however, based on the results of the bone biomechanical
testing, a-tocopherol supplementation does not appear to
restore the strength of healed fractured bones.
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